Chelation Beneficial in Iron-overloaded Patients at Lower Risk of Myelodysplastic Syndromes Chelation Beneficial in Iron-overloaded Patients at Lower Risk of Myelodysplastic Syndromes

Iron chelation therapy (ICT) with deferasirox led to longer event-free survival in iron-overloaded patients at low-to-intermediate risk of myelodysplastic syndrome (MDS) in a phase 2 study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news